SE0400346L - Steroider för cancerbehandling - Google Patents

Steroider för cancerbehandling

Info

Publication number
SE0400346L
SE0400346L SE0400346A SE0400346A SE0400346L SE 0400346 L SE0400346 L SE 0400346L SE 0400346 A SE0400346 A SE 0400346A SE 0400346 A SE0400346 A SE 0400346A SE 0400346 L SE0400346 L SE 0400346L
Authority
SE
Sweden
Prior art keywords
steroids
cancer treatment
cancer
treatment
Prior art date
Application number
SE0400346A
Other languages
English (en)
Other versions
SE0400346D0 (sv
SE527131C2 (sv
Inventor
Lars Pettersson
Original Assignee
Innoventus Project Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innoventus Project Ab filed Critical Innoventus Project Ab
Priority to SE0400346A priority Critical patent/SE527131C2/sv
Publication of SE0400346D0 publication Critical patent/SE0400346D0/sv
Priority to US10/587,561 priority patent/US20070142345A1/en
Priority to EP05711049A priority patent/EP1716166A2/en
Priority to PCT/SE2005/000188 priority patent/WO2005077968A2/en
Priority to CNA2005800047257A priority patent/CN101076538A/zh
Priority to AU2005212210A priority patent/AU2005212210A1/en
Priority to CA002552843A priority patent/CA2552843A1/en
Priority to JP2006553092A priority patent/JP2007522211A/ja
Publication of SE0400346L publication Critical patent/SE0400346L/sv
Publication of SE527131C2 publication Critical patent/SE527131C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0400346A 2004-02-13 2004-02-13 Steroider för cancerbehandling SE527131C2 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0400346A SE527131C2 (sv) 2004-02-13 2004-02-13 Steroider för cancerbehandling
US10/587,561 US20070142345A1 (en) 2004-02-13 2005-02-11 Steroids for cancer treatment
EP05711049A EP1716166A2 (en) 2004-02-13 2005-02-11 17-methylene- or 17-spiro-cyclopropane 7-substituted estra-1,3,5(10)-triene derivatives with anti-estrogenic activity
PCT/SE2005/000188 WO2005077968A2 (en) 2004-02-13 2005-02-11 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
CNA2005800047257A CN101076538A (zh) 2004-02-13 2005-02-11 用于癌症治疗的类固醇
AU2005212210A AU2005212210A1 (en) 2004-02-13 2005-02-11 Steroids for cancer treatment
CA002552843A CA2552843A1 (en) 2004-02-13 2005-02-11 Steroids for cancer treatment
JP2006553092A JP2007522211A (ja) 2004-02-13 2005-02-11 癌治療用ステロイド

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400346A SE527131C2 (sv) 2004-02-13 2004-02-13 Steroider för cancerbehandling

Publications (3)

Publication Number Publication Date
SE0400346D0 SE0400346D0 (sv) 2004-02-13
SE0400346L true SE0400346L (sv) 2005-08-14
SE527131C2 SE527131C2 (sv) 2005-12-27

Family

ID=31974231

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0400346A SE527131C2 (sv) 2004-02-13 2004-02-13 Steroider för cancerbehandling

Country Status (8)

Country Link
US (1) US20070142345A1 (sv)
EP (1) EP1716166A2 (sv)
JP (1) JP2007522211A (sv)
CN (1) CN101076538A (sv)
AU (1) AU2005212210A1 (sv)
CA (1) CA2552843A1 (sv)
SE (1) SE527131C2 (sv)
WO (1) WO2005077968A2 (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20071479A1 (it) * 2007-07-23 2009-01-24 Ind Chimica Srl Processo per la preparazione di 7alfa-[9-(4,4,5,5,5-pentafluortiopentil)nonil]estra-1,3,5(10)-trien-3,17beta-diolo
US20100174101A1 (en) * 2007-09-24 2010-07-08 Xi'an Liband Pharmaceutical Co., Ltd. Process for the manufacture of 7-alpha-[9-(4,4,5,5,5-penta fluoropentylsulphinyl) nonyl]estra-1,3,5-(10)- triene-3,17-beta-diol
US8669243B2 (en) * 2007-10-30 2014-03-11 The Wistar Institute Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer
US8575141B2 (en) * 2007-10-30 2013-11-05 The Wistar Institute Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer
JP5803136B2 (ja) * 2011-02-23 2015-11-04 東ソー株式会社 アミド含有スルフィド化合物、並びにその製造方法及び用途
JP5776200B2 (ja) * 2011-02-09 2015-09-09 住友化学株式会社 チオカルボン酸ｓ−（フルオロアルキル）エステルの製造方法
WO2014064712A2 (en) 2012-10-22 2014-05-01 Intas Pharmaceuticals Limited An improved process for the preparation of fulvestrant
US11318206B2 (en) 2014-03-28 2022-05-03 Aposense Ltd Compounds and methods for trans-membrane delivery of molecules
US9889202B2 (en) 2014-03-28 2018-02-13 Aposense Ltd. Compounds and methods for trans-membrane delivery of molecules
CA2944141C (en) * 2014-03-28 2023-03-28 Aposense Ltd. Compounds and methods for trans-membrane delivery of molecules
US9993563B2 (en) 2014-03-28 2018-06-12 Aposense Ltd. Compounds and methods for trans-membrane delivery of molecules
CN103965280B (zh) * 2014-05-21 2016-04-20 天津孚音生物科技发展有限公司 一种氟维司群中间体的制备方法
US10112962B2 (en) * 2014-07-02 2018-10-30 Xavier University Boron-based prodrug strategy for increased bioavailability and lower-dosage requirements for drug molecules containing at least one phenol (or aromatic hydroxyl) group
WO2017192991A1 (en) * 2016-05-06 2017-11-09 Xavier University Of Louisiana Selective estrogen receptor down-regulators (serds)
IL267919B2 (en) 2017-01-09 2024-03-01 Aposense Ltd Compounds and methods for transmembrane transfer of molecules
IL275773B2 (en) 2018-01-01 2025-07-01 Aposense Ltd Compounds and methods for trans-membrane delivery of molecules
CN111116428B (zh) * 2018-11-01 2023-09-15 江苏豪森药业集团有限公司 制备氟维司群的方法和中间体
EP4444318A4 (en) * 2021-12-06 2026-01-28 Amneal Pharmaceuticals Llc COMPOUNDS FOR CANCER TREATMENT
CN114805461B (zh) * 2022-04-14 2023-04-21 东南大学 一种苯环苄位c-h键氧化成酮的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9502921D0 (sv) * 1995-08-23 1995-08-23 Astra Ab New compounds

Also Published As

Publication number Publication date
JP2007522211A (ja) 2007-08-09
AU2005212210A1 (en) 2005-08-25
SE0400346D0 (sv) 2004-02-13
CN101076538A (zh) 2007-11-21
EP1716166A2 (en) 2006-11-02
WO2005077968B1 (en) 2007-01-04
WO2005077968A8 (en) 2006-11-16
CA2552843A1 (en) 2005-08-25
WO2005077968A3 (en) 2006-08-31
WO2005077968A2 (en) 2005-08-25
US20070142345A1 (en) 2007-06-21
SE527131C2 (sv) 2005-12-27

Similar Documents

Publication Publication Date Title
IL197217B (en) Novel anti-cd38 antibodies for the treatment of cancer
BRPI0810206A2 (pt) Método de tratar câncer
SE0400346L (sv) Steroider för cancerbehandling
DK1765391T3 (da) Bakterielle præparater til behandlingen af cancer
ZA200805877B (en) Pyridiazinone derivatives for tumour treatment
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
FR2872704B1 (fr) Pluritherapie contre le cancer
IL183059A0 (en) Cancer treatment method
IL187327A0 (en) Methods for treating drug resistant cancer
HUE038563T2 (hu) Rák kezelési eljárás
EP1594433A4 (en) SENSITIZING A CANCER THERAPY
PT1830847E (pt) Tratamento para o cancro
EP1755394A4 (en) METHOD OF TREATING CANCER
IL178920A0 (en) Treatment for pancreatic cancer
GB0428187D0 (en) Cancer treatment
IL179323A0 (en) Cancer treatment method
EP1789064A4 (en) ENHANCED ANTICANCER TREATMENT
GB0413346D0 (en) Treating cancer
FI20051207A0 (sv) Anordning för behandling av ryggen
ITMI20051107A1 (it) Metodo per il trattamento del cancro
IL179359A0 (en) Cancer treatment method
EP1802617A4 (en) CANCER TREATMENT METHOD
GB0404675D0 (en) Cancer treatment
GB0507685D0 (en) Cancer treatment

Legal Events

Date Code Title Description
NUG Patent has lapsed